|
22 Jan 2020 |
Kintai Therapeutics Advances Anti-Obesity Agent KTX-0200 into IND-Enabling Studies Following Positive Preclinical Data Demonstrating Sustained Weight Loss and Improved Health Markers
|
|
22 Jan 2020 |
INHIBITOR Therapeutics Receives prostate cancer IND Clearance from FDA
|
|
22 Jan 2020 |
Metacrine Demonstrates Best-in-Class FXR Drug Program with Positive Clinical Results in NASH Patients
|
|
22 Jan 2020 |
Akcea and Ionis report positive topline Phase 2 results of AKCEA-APOCIII-L Rx
|
|
22 Jan 2020 |
Jazz Pharmaceuticals Submits New Drug Application for JZP-258 for Cataplexy and Excessive Daytime Sleepiness Associated with Narcolepsy
|
|
22 Jan 2020 |
LB Pharmaceuticals Announces the Initiation of Patient Dosing in a First-in-Human Phase 1 Study of LB-102, a Novel Benzamide for the Treatment of Schizophrenia
|
|
22 Jan 2020 |
Celularity Announces FDA Clearance of Landmark IND for CYNK-001, an Allogeneic, Off-the-Shelf Cryopreserved NK Cell Therapy
|
|
22 Jan 2020 |
Ocuphire Pharma Announces In-License of Phase 2 Oral Small Molecule Drug Candidate for Diabetic Retinopathy and Diabetic Macular Edema from Apexian Pharmaceuticals
|
|
22 Jan 2020 |
Ra Pharmaceuticals Announces Clearance of IND Application for the HEALEY ALS Platform Trial
|
|
22 Jan 2020 |
Supernus Announces FDA Acceptance for Review of New Drug Application for SPN-812 for the Treatment of ADHD
|
|
22 Jan 2020 |
Targovax Announces Encouraging Data in Mesothelioma Study Combining ONCOS-102 and Standard of Care Chemotherapy
|
|
22 Jan 2020 |
FDA Approves TEPEZZA (TM) (teprotumumab-trbw) for the Treatment of Thyroid Eye Disease (TED)
|
|
22 Jan 2020 |
PDC*line Pharma raises €20 million in Series B financing round
|
|
21 Jan 2020 |
Biotech start-up Seekyo raises €800k with leverage from French Tech Seed Fund
|
|
21 Jan 2020 |
BeiGene Announces that the Phase 3 Clinical Trial of its Anti-PD-1 Antibody Tislelizumab in Patients with First-Line Squamous Non-Small Cell Lung Cancer Met the Primary Endpoint of Progression-Free Survival at Interim Analysis
|
|
21 Jan 2020 |
Rafael Pharmaceuticals Announces the Initiation of a Phase 1b/2 Clinical Trial of CPI-613 (devimistat) in Combination with Gemcitabine and Cisplatin in Patients with Biliary Tract Cancer
|
|
21 Jan 2020 |
Stealth BioTherapeutics Initiates First-in-Human Study of SBT-272
|
|
21 Jan 2020 |
Clene Nanomedicine Announces First Patient Dosed in the RESCUE-ALS Clinical Trial for the Treatment of Amyotrophic Lateral Sclerosis (ALS) with Lead Nanocatalytic Therapeutic, CNM-Au8
|
|
21 Jan 2020 |
Aldeyra Therapeutics Announces First Patient Enrolled in the Phase 3 INVIGORATE Trial in Allergic Conjunctivitis
|
|
21 Jan 2020 |
Ncardia and BlueRock Therapeutics Announce Collaboration Agreement and Licensing of Process Development Technologies for the Manufacture of iPSC-derived Cardiomyocytes
|
